bg
A

Apellis Pharma (APLS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Apellis Pharma (APLS)

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more

  • USD19.01
  • USD19.15
  • USD18.63
  • USD43.15
  • 9.90%
  • 776M
  • 292.31k
  • 2.32M
  • 2.4B
  • 16.10
  • -54.70%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.